Alpha 2.0
Login Register
» Authors » C Civin

C Civin

Explore the profile of C Civin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 223
Followers 0
Related Specialties
Oncology
Hematology
Allergy & Immunology
Top 10 Co-Authors
S Meuer
D Hart
M de Haas
R Schwartz-Albiez
D Simmons
P Andre
V Horejsi
E Clark
A Bensussan
H Zola
Published In
J Clin Oncol
Leukemia
Blood
Cytotherapy
Endocrinology
Affiliations
Soon will be listed here.
Recent Articles
1.
Ex vivo expansion of mafosfamide-purged PBPC products
McNiece I, Civin C, Harrington J, Kellner J, Malehorn M, Turney J, et al.
Cytotherapy . 2006 Oct; 8(5):459-64. PMID: 17050250
Background: Multiple studies have demonstrated that 'purging' of autografts with 4-hydroperoxycyclophosphamide (4HC) or the related compound mafosfamide (Mf), to eradicate residual leukemia, produces the best results associated with autologous blood...
2.
Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000
Ravindranath Y, Chang M, Steuber C, Becton D, Dahl G, Civin C, et al.
Leukemia . 2005 Sep; 19(12):2101-16. PMID: 16136167
From 1981 to 2000, a total of 1823 children with acute myeloid leukemia (AML) enrolled on four consecutive Pediatric Oncology Group (POG) clinical trials. POG 8101 demonstrated that the induction...
3.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Tissue Antigens . 2002 Apr; 58(6):425-30. PMID: 11929596
The most recent Human Leucocyte Differentiation Antigen Workshop ("HLDA7") took place in 2000 in Harrogate, UK and the proceedings are about to be published (Leucocyte Typing VII). New Sections were...
4.
CD antigens 2001: aims and results of HLDA Workshops
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Stem Cells . 2001 Nov; 19(6):556-62. PMID: 11713348
No abstract available.
5.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
J Leukoc Biol . 2001 Nov; 70(5):685-90. PMID: 11698486
This paper reviews the Seventh Human Leucocyte Differentiation Antigen (HLDA7) workshop. Due to the limitations of "blind" antibody screening, which had been evident at the previous meeting in 1996, participants...
6.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Eur J Immunol . 2001 Oct; 31(10):2841-7. PMID: 11592058
No abstract available.
7.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Cell Immunol . 2001 Oct; 211(2):81-5. PMID: 11591111
No abstract available.
8.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Immunology . 2001 Sep; 103(4):401-6. PMID: 11529929
No abstract available.
9.
CD antigens 2001
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, et al.
Int Immunol . 2001 Aug; 13(9):1095-8. PMID: 11526089
No abstract available.
10.
Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study
Camitta B, Mahoney D, LEVENTHAL B, Lauer S, Shuster J, Adair S, et al.
J Clin Oncol . 1994 Jul; 12(7):1383-9. PMID: 8021728
Purpose: To determine the potential efficacy and toxicity of intravenous (i.v.) methotrexate (MTX) and mercaptopurine (MP) as postremission intensification treatment for children with B-lineage acute lymphoblastic leukemia (ALL) at higher...